» Articles » PMID: 12871267

Inflammation and Thrombosis

Overview
Publisher Elsevier
Specialty Hematology
Date 2003 Jul 23
PMID 12871267
Citations 125
Authors
Affiliations
Soon will be listed here.
Abstract

Systemic inflammation is a potent prothrombotic stimulus. Inflammatory mechanisms upregulate procoagulant factors, downregulate natural anticoagulants and inhibit fibrinolytic activity. In addition to modulating plasma coagulation mechanisms, inflammatory mediators appear to increase platelet reactivity. In vivo, however, natural anticoagulants not only prevent thrombosis, but they also dampen inflammatory activity. Some insights into the evolution and linkages between inflammatory mechanisms and the coagulation/anticoagulation mechanisms have become evident from recent structural studies. This review will summarize the interactions between inflammation and coagulation.

Citing Articles

The effects of coagulation factors on the risk of autoimmune diseases: A Mendelian randomization study.

Li S, Zhou C, Li W, Kang L, Mu H Medicine (Baltimore). 2025; 103(52):e40893.

PMID: 39969330 PMC: 11688059. DOI: 10.1097/MD.0000000000040893.


Hemostatic Profile and Serum Levels of Interferon Gamma-Induced Protein 10 (IP-10) in Neonates Born to Mothers with COVID-19 During the Peripartum Period.

Sokou R, Bikouli E, Tsantes A, Halvatsiotis P, Houhoula D, Taliaka Kopanou P Int J Mol Sci. 2025; 26(3).

PMID: 39940970 PMC: 11818117. DOI: 10.3390/ijms26031201.


Targeted anti-cancer agents and risk of venous thromboembolism.

Verso M, Moik F, Graziani M, Cohen A Haematologica. 2024; 109(12):3868-3878.

PMID: 39618297 PMC: 11609817. DOI: 10.3324/haematol.2023.284778.


Flow Dynamic Factors Correlated With Device-Related Thrombosis After Left Atrial Appendage Occlusion.

Vogl B, Vitale E, Ahn S, Sularz A, Chavez Ponce A, Lo Russo G JACC Adv. 2024; 3(11):101339.

PMID: 39493311 PMC: 11530902. DOI: 10.1016/j.jacadv.2024.101339.


Validation of risk assessment scores in predicting venous thromboembolism in patients with lung cancer receiving immune checkpoint inhibitors.

Zhang J, Xie Y, Yang L, Yang M, Xu R, Liu D BMC Pulm Med. 2024; 24(1):507.

PMID: 39390440 PMC: 11468413. DOI: 10.1186/s12890-024-03323-z.